Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-373
Invest New Drugs July 1, 2006; 24 (4): 263-80.

The Wnt-dependent signaling pathways as target in oncology drug discovery.

Janssens N , Janicot M , Perera T .


Abstract
Our current understanding of the Wnt-dependent signaling pathways is mainly based on studies performed in a number of model organisms including, Xenopus, Drosophila melanogaster, Caenorhabditis elegans and mammals. These studies clearly indicate that the Wnt-dependent signaling pathways are conserved through evolution and control many events during embryonic development. Wnt pathways have been shown to regulate cell proliferation, morphology, motility as well as cell fate. The increasing interest of the scientific community, over the last decade, in the Wnt-dependent signaling pathways is supported by the documented importance of these pathways in a broad range of physiological conditions and disease states. For instance, it has been shown that inappropriate regulation and activation of these pathways is associated with several pathological disorders including cancer, retinopathy, tetra-amelia and bone and cartilage disease such as arthritis. In addition, several components of the Wnt-dependent signaling pathways appear to play important roles in diseases such as Alzheimer''s disease, schizophrenia, bipolar disorder and in the emerging field of stem cell research. In this review, we wish to present a focused overview of the function of the Wnt-dependent signaling pathways and their role in oncogenesis and cancer development. We also want to provide information on a selection of potential drug targets within these pathways for oncology drug discovery, and summarize current data on approaches, including the development of small-molecule inhibitors, that have shown relevant effects on the Wnt-dependent signaling pathways.

PubMed ID: 16683072
PMC ID: PMC2780666
Article link: Invest New Drugs


Species referenced: Xenopus
Genes referenced: ctnnb1
GO keywords: canonical Wnt signaling pathway

Disease Ontology terms: cancer [+]
OMIMs: TETRAAMELIA SYNDROME 1; TETAMS1

Article Images: [+] show captions
References [+] :
Aggarwal, Anticancer potential of curcumin: preclinical and clinical studies. 2003, Pubmed